Gornitzky represented the underwriters, led by TD Cowen and Guggenheim Securities on the offering. UroGen Pharma Ltd. secured a USD 107.5 million follow-on public offering of...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here